Loading…
Loading…
EQUITY / NASDAQ · XNGS
Bioceres Crop Solutions Corp
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →07/01/2024 – 06/30/2025 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗0.3418 USD · 0%
Observed: Oct 2, 2026, 8:00 PM · TickerLayer indicative price; may be delayed
Powered by TickerLayer
10/02/2026 · 0.3418 USD · Volume 73,392
251 actual observations · Latest bar: 2026-10-02 · Market data is indicative; provider terms apply.
3 available financial reports
Research reports →SEC FINANCIAL REPORTS
07/01/2024 – 06/30/2025 · Units
| Metric | 2025 / Year end | 2024 / Year end | Change |
|---|---|---|---|
| Revenue | 335,108,850 USD | 464,782,802 USD | -27.90% |
| Operating profit | -2,235,962 USD | 45,852,923 USD | -104.88% |
| Net income | -58,845,253 USD | 7,288,983 USD | -907.32% |
| Operating cash flow | 49,905,611 USD | 41,716,586 USD | +19.63% |
| Cash and cash equivalents | 32,695,079 USD | 44,473,270 USD | -26.48% |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2025 / Year end07/01/2024 – 06/30/2025ConsolidatedUnits · USD | 2024 / Year end07/01/2023 – 06/30/2024ConsolidatedUnits · USD | 2023 / Year end07/01/2022 – 06/30/2023ConsolidatedUnits · USD |
|---|---|---|---|
| Cash and cash equivalentsBalance sheet | 32,695,079 USD | 44,473,270 USD | — |
| Financing cash flowCash flow statement | -50,706,103 USD | -10,055,867 USD | 32,954,000 USD |
| Gross profitIncome statement | 131,683,978 USD | 186,560,990 USD | 184,599,940 USD |
| Investing cash flowCash flow statement | -6,128,891 USD | -28,728,255 USD | -25,725,670 USD |
| Net incomeIncome statement | -58,845,253 USD | 7,288,983 USD | 20,174,599 USD |
| Operating cash flowCash flow statement | 49,905,611 USD | 41,716,586 USD | 2,588,792 USD |
| Operating profitIncome statement | -2,235,962 USD | 45,852,923 USD | 54,183,965 USD |
| RevenueIncome statement | 335,108,850 USD | 464,782,802 USD | 420,056,993 USD |
| Total assetsBalance sheet | 763,645,080 USD | 852,548,194 USD | — |
| Total equityBalance sheet | 295,218,562 USD | 351,380,852 USD | 330,496,107 USD |
| Total liabilitiesBalance sheet | 468,426,518 USD | 501,167,342 USD | — |
| Report source | Open report ↗ Published: 11/10/2025 | Open report ↗ Published: 11/10/2025 | Open report ↗ Published: 11/10/2025 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.